Transgene SA
Common Stock · EUR · EPA
Price
€0.831
Cap
€47.28M
Earnings
—
30d Trend
+9.8%
BRAIN47 SIGNAL
Raw weighted: 38×Macro 0.99 (−1%)=38
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Limited short-term thesis
BRAIN47'S ASSESSMENT
I rate Transgene SA at 38/100 — a WEAK reading on the Brain47 Signal. The strongest factor is technical at 52/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.
DETAILED ANALYSIS
Limited short-term thesis. Technical (52) and Quality (51) are the primary strengths. I note that fundamentals is the weakest area at 15/100 — this warrants monitoring. I classify this as a speculative position — risk characteristics and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.